Double Duty: Viagra Shows Promise in Lowering Alzheimer’s Disease Risk by 60%

A recent study conducted by researchers at Mount Sinai Medical Center in New York has revealed a potential breakthrough in the fight against Alzheimer’s disease, as first reported by the New York Post. 

The study, which examined the effects of the well-known erectile dysfunction medication Viagra (sildenafil), indicates that the drug may reduce the risk of developing Alzheimer’s by a significant margin.

The research involved over 27,000 participants aged 65 and older. Half of these individuals had been prescribed sildenafil, while the other half had not. The key discovery was that Viagra functions by inhibiting an enzyme known as PDE5, which is found in the brains of Alzheimer’s patients and is notably increased in the memory management region of the brain.

The findings, as reported by study author Xingyue Huo, demonstrated a substantial 60% reduction in the risk of developing Alzheimer’s disease among those who had taken Viagra. This has the potential to make a substantial impact, particularly given the grim statistics related to Alzheimer’s in the United States. 

Currently, approximately 6.7 million Americans aged 65 and older are living with the disease, with projections suggesting a rise to 12.7 million by 2050, according to the Alzheimer’s Association.

The study also highlighted other potential benefits of Viagra. It was shown to increase blood supply, which may lead to improved brain health and potentially serve as a treatment for dementia.

These findings follow a prior study released in January, which revealed that Viagra can lower the risk of heart disease in men by up to 39%, reducing the likelihood of heart failure and unstable angina. 

Viagra users were also found to have a longer lifespan, with their risk of early death dropping by 25%. These multiple potential health benefits suggest that Viagra may have a broader impact on overall well-being than previously understood.

Information for this story was found via the New York Post, and the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

The post Double Duty: Viagra Shows Promise in Lowering Alzheimer’s Disease Risk by 60% appeared first on the deep dive.

buy
sell
medical